Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°æºÎ ¸²ÇÁÀýÀÇ ÀüÀ̼º ¾ÏÁ¾°ú ¿ø¹ß¼º ¾ÏÁ¾¿¡¼­ p53, E-cadherin ¹× nm23 ´Ü¹éÀÇ ¹ßÇö Immunohistochemical Expression of p53, E-cadherin, and nm23 Proteins in Metastatic Carcinoma of Neck Lymph Node and Corresponding Primary Carcinoma

´ëÇѺ´¸®ÇÐȸÁö 2000³â 34±Ç 9È£ p.615 ~ 624
±èÁ¾±¹, ±Ç¿ÀÁØ, ±èº´Çå,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÁ¾±¹ ( Kim Jong-Kook ) 
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ ¸¶»ê»ï¼ºº´¿ø Çغκ´¸®°ú

±Ç¿ÀÁØ ( Kwon O-Jun ) 
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ ¸¶»ê»ï¼ºº´¿ø Çغκ´¸®°ú
±èº´Çå ( Kim Byung-Heon ) 
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ ¸¶»ê»ï¼ºº´¿ø Çغκ´¸®°ú

Abstract


This study was carried out to evaluate the immunohistochemical expressions of p53, E-cadherin, and nm23 proteins in 114 cases of metastatic carcinoma of the neck lymph node (MTLNCA) and corresponding primary carcinoma (PRCA). The positive expressions of p53, E-cadherin, and nm23 proteins were 62.3%, 58.8% and 64.0%, respectively in PRCA, and 40.4%, 38.6%, and 43.9%, respectively in MTLNCA with significant down-regulation from PRCA to MTLNCA (p£¼0.05). The down-regulation was correlated with female gender, moderate and poor differentiation, and adenocarcinoma in p53 protein, female gender, respiratory and gastrointestinal carcinoma in E-cadherin protein, and female gender, respiratory carcinoma, moderate differentiation, and squamous cell carcinoma in nm23 protein (p£¼0.05). There was no significant relationship among expressions of p53, E-cadherin, and nm23 proteins (p£¾0.05). In conclusion, these results suggest that the expressions of p53, E-cadherin, and nm23 proteins seem to be down-regulated from PRCA to MTLNCA and this down-regulation may play a role in invasion and metastasis.

Å°¿öµå

Metastatic carcinoma;Neck lymph node;p53;E-cadherin;nm23

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS